Subscribe

Real Clinics. Real Patients. Real Oncology.

Home / Topics / Cancer Types / Hematologic Malignancies

Home /

Hematologic Malignancies

Hematologic Malignancies

Home / Topics / Cancer Types / Hematologic Malignancies

Home /

Hematologic Malignancies

Home / Topics / Cancer Types / Hematologic Malignancies

Home /

News / Hematologic Malignancies

FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

FDA approves D-VRd quadruplet for transplant-ineligible newly diagnosed multiple myeloma based on CEPHEUS trial PFS and MRD negativity gains.

April 16, 2026

Image without description (no attachment ID found)

Hematologic Malignancies

Image without description (no attachment ID found)
FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

April 16, 2026

Image without description (no attachment ID found)
FDA Approvals

Reconsidering Venetoclax Dosing With Azole Antifungals

Grant Drew, PharmD; Kiwon Park, PharmD; et al.

April 16, 2026

Image without description (no attachment ID found)
FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

April 16, 2026

Image without description (no attachment ID found)
FDA Approvals

Reconsidering Venetoclax Dosing With Azole Antifungals

Grant Drew, PharmD; Kiwon Park, PharmD; et al.

April 16, 2026

News & Insights

Image without description (no attachment ID found)
FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

April 16, 2026

Image without description (no attachment ID found)
FDA Approvals

Reconsidering Venetoclax Dosing With Azole Antifungals

Grant Drew, PharmD; Kiwon Park, PharmD; et al.

April 16, 2026

Podcasts

No results were found

Leukemia

Lymphoma

Multiple Myeloma

What are you
looking for?

POPULAR SEARCHES

Blood-Based Tests

Breast Cancer

Cancer Types

Cellular Therapies (e.g., CAR T)